Oncopeptides

1.81 SEK

-6.60 %

Less than 1K followers

ONCO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

-6.60 %
+31.92 %
+6.47 %
-62.33 %
-68.79 %
+8.36 %
-67.44 %
-97.25 %
-93.73 %
Market cap
715.47M SEK
Turnover
15.73M SEK
Revenue
71.12M
EBIT %
-315.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/8
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.